Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0Z3RR
|
||||
| Former ID |
DIB018029
|
||||
| Drug Name |
S 17092
|
||||
| Synonyms |
S17092; S-17092
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Non-small cell lung cancer [ICD10:C33-C34] | Clinical trial | [1] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C22H28N2O2S
|
||||
| InChI |
InChI=1S/C22H28N2O2S/c25-21(18-13-17(18)15-6-2-1-3-7-15)24-19-9-5-4-8-16(19)12-20(24)22(26)23-10-11-27-14-23/h1-3,6-7,16-20H,4-5,8-14H2/t16-,17-,18+,19-,20-/m0/s1
|
||||
| InChIKey |
NXSXRIHXEQSYEZ-KNJMJIDISA-N
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | Prolyl endopeptidase | Target Info | Inhibitor | [2] | |
| KEGG Pathway | Renin-angiotensin system | ||||
| PANTHER Pathway | Vasopressin synthesis | ||||
| References | |||||
| REF 1 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6565). | ||||
| REF 2 | J Med Chem. 2010 May 13;53(9):3423-38.Inhibitors of prolyl oligopeptidases for the therapy of human diseases: defining diseases and inhibitors. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.